Quest Diagnostics
DGX
652 hedge funds and large institutions have $12B invested in Quest Diagnostics in 2018 Q1 according to their latest regulatory filings, with 81 funds opening new positions, 173 increasing their positions, 270 reducing their positions, and 52 closing their positions.
56% more first-time investments, than exits
New positions opened: 81 | Existing positions closed: 52
3% more funds holding
Funds holding: 631 → 652 (+21)
2% more capital invested
Capital invested by funds: $11.8B → $12B (+$223M)
0.38% more ownership
Funds ownership: 88.28% → 88.67% (+0.38%)
3% less call options, than puts
Call options by funds: $35.6M | Put options by funds: $36.9M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
36% less repeat investments, than reductions
Existing positions increased: 173 | Existing positions reduced: 270
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FMI
Fiduciary Management Inc
Milwaukee,
Wisconsin
|
+$163M |
| 2 |
BlackRock
New York
|
+$110M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$88.2M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$60M |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$53.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$84.7M |
| 2 |
Millennium Management
New York
|
-$66.1M |
| 3 |
Morgan Stanley
New York
|
-$57.1M |
| 4 |
Renaissance Technologies
New York
|
-$53.8M |
| 5 |
APG Asset Management
Amsterdam,
Netherlands
|
-$46.8M |
DGX Hedge Fund Activity: Q1 2018 in Review
652 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q1 2018, worth a combined $12B — up 1.9% from $11.8B a quarter earlier.
Buyers outnumbered sellers: 81 funds opened new DGX positions and 52 closed out — a net gain of 29 holders — while 173 added to existing stakes and 270 trimmed.
The largest buyer was Fiduciary Management Inc, adding an estimated $163M. The largest seller was Janus Henderson Group, cutting an estimated $84.7M.
- 652 institutional investors held Quest Diagnostics (DGX) as of Q1 2018, up from 631 in Q4 2017.
- Funds reported $12B of Quest Diagnostics stock for Q1 2018, up 1.9% quarter-over-quarter.
- 81 funds opened new Quest Diagnostics positions in Q1 2018 and 52 closed out, a net change of +29 holders.
- The largest Quest Diagnostics buyer in Q1 2018 was Fiduciary Management Inc, an estimated $163M added.
- The largest Quest Diagnostics seller in Q1 2018 was Janus Henderson Group, an estimated $84.7M sold.
Based on aggregated 13F filings for Q1 2018.